Imatinib Treatment of Chronic Myeloid Leukemia Reveals a Preexisting CALR-mutated Essential Thrombocythemia - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles HemaSphere Year : 2018

Imatinib Treatment of Chronic Myeloid Leukemia Reveals a Preexisting CALR-mutated Essential Thrombocythemia

Domains

Cancer
Fichier principal
Vignette du fichier
2018_Bouet A_HemasphereEq7.pdf (783.04 Ko) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

inserm-02541794 , version 1 (14-04-2020)

Identifiers

Cite

Anaïse Blouet, Marie-Christine Rousselet, Yannick Le Bris, Bénédicte Ribourtout, Anne Bouvier, et al.. Imatinib Treatment of Chronic Myeloid Leukemia Reveals a Preexisting CALR-mutated Essential Thrombocythemia. HemaSphere, 2018, 2 (1), pp.e29. ⟨10.1097/HS9.0000000000000029⟩. ⟨inserm-02541794⟩
47 View
50 Download

Altmetric

Share

Gmail Facebook X LinkedIn More